Abstract:BACKGROUND:During the transfusion of blood components, the transfer of allogeneic donor white blood cells (WBCs) can mediate transfusion-associated graft-versus-host disease (TA-GVHD). To minimize the reaction, exposure of blood products to gamma irradiation is currently the standard of care. The aim of our study was to evaluate and compare hemostatic function, transfusion efficacy, and safety of gamma-irradiated single-donor apheresis platelet concentrates (PCs) and of conventional non-irradiated PCs in patients with chemotherapy-induced thrombocytopenia. METHODS:20 double-dose single-donor leukoreduced PCs were split in two identical units; one was gamma-irradiated with 25 Gy (study arm A) and the other remains non-irradiated (study arm B). Both units were stored under equal conditions. Hematologic patients were randomly assigned to receive gamma-irradiated or conventional non-irradiated PCs. Hemostatic function was evaluated by thrombelastography (TEG). TEG measurements were taken pre transfusion and 1 and 24 h post transfusion. TEG profiles were measured, noting the time to initiate clotting (R), the angle of clot formation (α), and the maximum amplitude (clot strength (MA)). Whole blood samples were collected from these thrombocytopenic patients at 1 and 24 h for PLT count increments (CIs) and corrected count increments (CCIs) with assessments of transfusion efficacy. Time to next PLT transfusion, transfusion requirement of RBCs, active bleeding, and adverse events (AEs), were analyzed. RESULTS:No differences could be found in hemostatic function parameters (MA, R, and α) between study arms A and B (all p values > 0.096) pre transfusion as well as 1 and 24 h post transfusion. No differences between study arms A and B were observed for mean (± standard deviation (SD)) 1-hour CCI (12.83 ± 6.33 vs. 11.59 ± 5.97) and 24-hour CCI (6.56 ± 4.10 vs. 5.76 ± 4.05). Mean 1-hour CI and 24-hour CI were not significantly different in both study arms (p = 0.254 and p = 0.242 respectively). Median time to the next PC transfusion after study PC was not significantly different between groups: (2.4 vs. 2.2 days, p = 0.767). No differences could be found in transfusion requirement of red blood cells (p = 0.744) between both study arms. There were also no regarding bleeding, adverse events, and acute transfusion reaction(s). CONCLUSIONS:This study confirms safety of gamma-irradiated PCs for treatment thrombocytopenia. Hemostatic function, transfusion efficacy, bleeding, and safety of single-donor apheresis PCs treated with gamma irradiation versus untreated control PCs are comparable.

Application of the thrombelastogram in the evaluation of coagulation functions pre/post plateletpheresis

Application of thrombelastography in patients with end-stage hepatocirrhosis during liver transplantation: 27 cases report

Application of thromboelastography for children undergoing cardiac surgery with cardiopulmonary bypass

Thrombelastogram monitoring in autologous blood transfusion during splenectomy in the treatment of portalhy pertension

Regulation of Coagulation Function in Patients with Cirrhosis Splenectomy by Thromboelastography

The clinical use of thrombelastography

Thromboelastography may guide postoperative transfusion therapy after abdominal surgery

Building And Clinical Use Of Activated Plasma Clotting Time Test And The Value Of Apct On Predicting The Bleeding Due To Leukemia Chemotherapy-Induced Thrombocytopenia

The significance of thromboelastography and coagulation tests in guiding cardiac surgery patients perioperative blood transfusion

Global hemostasis testing thromboelastography: old technology, new applications

Thromboelastography As a Tool for Monitoring Blood Coagulation Dysfunction after Adequate Fluid Resuscitation Can Predict Poor Outcomes in Patients with Septic Shock.

Clinical Study on Thromboelastography-Indicated Postoperative Blood Requirements after Abdominal Surgery

Risk factor prediction of severe postoperative acute kidney injury at stage 3 in patients with acute type A aortic dissection using thromboelastography

Analysis of TEG changes on 72 cases of perioperative coronary artery bypass grafting

The Difference of Thrombelastogram in Patients with Cerebral Infarction before and after the Treatment of Intravenous Thrombolysis

Hemostatic function and transfusion efficacy of apheresis platelet concentrates treated with gamma irradiation in use for thrombocytopenic patients.

Changes in blood coagulation and diagnosis of early coagulation abnormalities by thrombelastography in patients at nutritional risk

A Clinical Study on TEG for the Evaluation of Blood Coagulation State of Patients with Gastric Cancer during Perioperative Period

Thromboelastography-guided Intraoperative Platelet Transfusion in Pediatric Heart Surgery

Comparison between thromboelastography and the conventional coagulation test in detecting effects of antiplatelet agents after endovascular treatments in acute ischemic stroke patients: A STROBE-compliant study.

Utility of thromboelastography with platelet mapping (TEG-PM) for monitoring platelet transfusion in qualitative platelet disorders